University Clinic of Regensburg, Regensburg, Germany.
Mod Rheumatol. 2010 Jun;20(3):311-5. doi: 10.1007/s10165-010-0273-y. Epub 2010 Feb 19.
We report on a 33-year-old female patient with a relatively mild clinical case of TNF-receptor associated periodic syndrome (TRAPS) and her 58-year-old father in whom end-stage renal disease due to TRAPS-related AA-amyloidosis has already developed. TRAPS was caused by a I170N mutation that has previously not been associated with amyloidosis. It remains unclear if an only mildly affected patient such as ours would benefit from treatment considering her father's severe course of disease. The relevant literature on this problem is reviewed.
我们报告了一例 TNF 受体相关周期性综合征(TRAPS)的 33 岁女性患者及其 58 岁的父亲,其父亲因 TRAPS 相关的 AA 淀粉样变性已发展为终末期肾病。TRAPS 由 I170N 突变引起,此前与淀粉样变性无关。尚不清楚像我们这样仅有轻度受累的患者是否会从治疗中受益,因为她的父亲疾病的严重程度。对该问题的相关文献进行了回顾。